Bone Biologics Corp. BBLG
0.50
0.01
2.04%
as of 25 Sep
- Market cap
- $1.4M
- P/E
- 0.0×
Follow BBLG
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(80.46%) | (70.17%) | (75.40%) | (54.96%) | |
| (75.76%) | (64.38%) | (70.20%) | (50.55%) | ||
ROIC |
0.00% | (4,680.27%) | (1,340.96%) | 0.00% | |
Return on Tangible Assets |
(65.59%) | (57.81%) | (61.20%) | (73.66%) | |
Average Days of Receivables |
— | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.85) | (2.29) | (1.43) | (1.46) | |
Free Cash Flow |
(3.33) | (2.69) | (2.57) | (2.63) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(27.60%) | (25.12%) | (27.93%) | (33.04%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 0.87 | 0.90 | 0.91 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.85) | (2.29) | (1.43) | (1.46) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates